Human 15-LOX-1 active site mutations alter inhibitor binding and decrease potency.

about

Human 15-LOX-1 active site mutations alter inhibitor binding and decrease potency.

Item

http://www.wikidata.org/entity/Q39372521

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Human 15-LOX-1 active site mutations alter inhibitor binding and decrease potency.

@en

Human 15-LOX-1 active site mutations alter inhibitor binding and decrease potency.

@nl

type

Item

label

Human 15-LOX-1 active site mutations alter inhibitor binding and decrease potency.

@en

Human 15-LOX-1 active site mutations alter inhibitor binding and decrease potency.

@nl

prefLabel

Human 15-LOX-1 active site mutations alter inhibitor binding and decrease potency.

@en

Human 15-LOX-1 active site mutations alter inhibitor binding and decrease potency.

@nl

P1476

Human 15-LOX-1 active site mutations alter inhibitor binding and decrease potency.

@en

P2093

Chakrapani Kalyanaraman

http://www.w3.org/2001/XMLSchema#string

Christopher van Hoorebeke

http://www.w3.org/2001/XMLSchema#string

J Cody Freedman

http://www.w3.org/2001/XMLSchema#string

Joshua Deschamps

http://www.w3.org/2001/XMLSchema#string

Michelle Armstrong

http://www.w3.org/2001/XMLSchema#string

Theodore Holman

http://www.w3.org/2001/XMLSchema#string

Thomas Horn

http://www.w3.org/2001/XMLSchema#string

P2860

A primary determinant for lipoxygenase positional specificity

The structure of human 15-lipoxygenase-2 with a substrate mimic

Structural and functional characterization of second-coordination sphere mutants of soybean lipoxygenase-1

Conformational flexibility in mammalian 15S-lipoxygenase: Reinterpretation of the crystallographic data

Crystal structure of 12-lipoxygenase catalytic-domain-inhibitor complex identifies a substrate-binding channel for catalysis

The structure of mammalian 15-lipoxygenase reveals similarity to the lipases and the determinants of substrate specificity

Role of arachidonic acid lipoxygenase metabolites in the regulation of vascular tone

Genetic regulation of metabolic pathways in beta-cells disrupted by hyperglycemia.

A potent and selective inhibitor targeting human and murine 12/15-LOX.

Novel lipoxygenase inhibitors as neuroprotective reagents.

P304

5380-5387

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BMC.2016.08.063

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Matthew P. Jacobson

P577

2016-08-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27647374

http://www.w3.org/2001/XMLSchema#string

P932

5065787

http://www.w3.org/2001/XMLSchema#string